AFP and hepatocellular carcinoma: An important aspect is that in patients with AFP levels below 200 ng/mL, the diagnostic efficiency was good because the use of circSMARCA5 achieved an AUC of 0.847 in discriminating HCC vs. Hepatitis patients and an AUC of 0.706 in the HCC vs. Cirrhosis group.